The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32598164.
- Also identified by DOI 10.7326/M20-3106 and PMC identifier 7384266.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although the number of clinical trials for patients with COVID-19 is increasing, many exclude pregnant women as participants or do not address pregnancy. This commentary discuss why pregnancy women should be included in clinical trials of interventions for COVID-19.
Medical subject headings
- Clinical Trials as Topic
- Coronavirus Infections
- Pneumonia, Viral
- Pregnancy Complications, Infectious
- Pregnant People
- Research Subjects